ALKS
Alkermes Plc
NASDAQ · Healthcare · Biotechnology · IE
$45.15
−1.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 85.49x
- P/E 2028E
- 46.44x
- P/S forward
- 4.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- 112.03x
- PEG TTM
- —
- Price / book
- 4.19x
- Price / sales
- 4.54x
- Price / cash flow
- 30.15x
Enterprise value
- Enterprise value
- $8.5B
- EV / sales
- 5.09x
- EV / EBITDA
- 38.94x
- EV / EBIT
- 72.39x
- Market cap
- $7.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026